🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr. Jae-Lyun Lee PhII mFOLFIRINOX for #1L adv #urachalcancer n=21 ORR 61.9% (2 CRs) Median PFS 9.3 mos Median OS 26.4 mos No febrile neutropenia or G4 events w/prophylactic GCSF on protocol #ASCO24 OncoAlert

⭐️ RAPID ORALS RENAL ⭐️ “Systemic treatments in favorable and very favorable risk metastatic renal cell carcinoma (mRCC): Real world evidence from the International mRCC Database Consortium (IMDC).” Dr Martin Zarba Daniel Heng IMDC FAV (n = 611) ✅ Nivo/Ipi: ORR (35%),

🏆 State-of-the-Art Diagnostic and Therapeutic Strategies in Renal Cell Carcinoma: Current Advances and Future Frontiers 🏆 “Advanced Sequencing and Targeted Therapy Strategies in Renal Cell Carcinoma: How Can We Help More Patients Not at the Expense of Toxicity?” Yu-Wei Chen, MD, MS

IMDC analysis of very favorable risk mRCC (0 risk factors, time from diagnosis to systemic therapy ≥3 yrs, no brain/liver/bone mets, KPS ≥90%) 🔹IO+VEGF & VEGF mono associated with best OS outcomes, compared to ipi/nivo (2-yr: ~90% vs 71%) 🔹ORR: 55-58% with VEGF +/- IO vs

Bloodless R0 en-bloc TURBT for solitary pT2a #bladdercancer with Quanta Surgery #virtualbasket mode. Smooth resection surface, specimen retrieval with bag, 30min OR time. Are there any arguments left for classic TURBT? #urosome #urology #lasers #endoscopy

Exciting advances in prostate cancer treatment at #ASCO24! ⚪️ JNJ-6420, a novel anti-hK2 Ab-based targeted #radiotherapy, shows promising results in heavily pretreated mCRPC patients. ⚪️ Despite notable adverse events, profound and durable responses were observed at ≥150 μCi

📌 Prostate cancer ⏩ Phase Ib trial -Tarlatamab Tarlatamab showed manageable safety profile in Neuroendocrine #Prostate #Cancer, showing antitumor activity on DLL3 expression. #ASCO24 OncoAlert

Great to have Tom Powles at #UroTrials in Düsseldorf. Prediction: 80% less cystectomies in the next five years given recent advances in the field. So rCx only in case of local complications/bleeding in the future? Axel S. Merseburger jim catto Benjamin J. Davies MD Alexander Kutikov MD

⚠️⚠️⚠️Publication alert!⚠️⚠️⚠️ nature.com/articles/s4155… Congratulations #BrabletzLab and The Koeberle Lab for this amazing study. Happy to have played a tiny role #ferroptosis #lipidmetabolism #cancerplasticity

Honored to share the 🇺🇾🇦🇷experience with #PaclitaxelDextranCoatedBalloon for Post Operative Ureteral Strictures during #WCET24 🇰🇷 #SEOUL BS1:15 📁 #JavierZeballos Sociedad Argentina de Urología🇦🇷 Oficina Residentes CAU Oficina Residentes CAU Endourological Society Luis Rico Alexander Ruebben, MD Amer. Urol. Assn. European Association of Urology (EAU) European School of Urology (EAU ESU)

Winning the Maximilian Nitze Price of the DGU #DGU24 is the most important scientific award in academic urology and urooncology in Germany. Niklas Klümper made it 🎉🍾!!! Well deserved for your hard and dedicated work for advancing medical care for urlthelial cancer

Ready for a very interesting day in Athens on how to progress with prostate cancer research! A big thanks to the Apollo-program!

After several years immersed in clinic and teaching, the Apollo project has been an incredible encounter to start improving my research skills. It is an honor to have met my mentor steven joniau and the rest of the faculty. Long live the Apollo project and thanks to @IpsenGroup

We had some intense brainstorming and active discussions on research topics and problems in #prostatecancer at Apollo meeting by @IpsenGroup👍 It was priceless to learn the personal stories of our mentors and to get an expert advice on our ongoing projects. Thank you!🙌

1/5 Big news from Aguilar Lab! Check out our first preprint! We’ve developed a new prostate organoid model to crack the mystery of E. coli prostatitis, a common, tough-to-treat infection in men. Our model reveals how these bacteria get in and thrive. #UPEC #Organoids #UTI

Special thanks to the Single Cell Center Würzburg Single-Cell Center Würzburg, Emmanuel Saliba, and chariskalogirou for their support!

Nice summary of where we are with the DRE. Academic urologists--do you still ask your team to include with their H&P? Is Era of the Digital Rectal Examination (DRE) for Prostate ... : JU Open Plus journals.lww.com/juop/fulltext/…

If you ever wondered how advanced urothelial carcinoma evolves during metastatic spread 👉 Read our review about #bladder cancer #metastsis and #evolution in Nature Reviews Urology ! Thanks for highlighting Sabine D. Brookman-May Niklas Klümper Top Biomedical Science UroToday.com OncoAlert

Apply now, spread the word: three (3) fully funded Helmholtz research groups (assistant prof level) with attractive packages. Topics: RNA-based medicine, microbial RNA, and RNA-based infection research incl. RNA technologies. Great environment for young people. Come and join us.